Lloyd Inc. Recalls Levothroid Tablets Due to cGMP Deviations
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium) tablets due to cGMP deviations and insufficient stability data.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product may cause temporary or medically reversible health consequences. The source cites cGMP deviations and insufficient stability data without reporting specific injuries or illnesses, fitting the criteria for a moderate severity score.
Plain-English summary
Lloyd Inc. of Iowa is recalling 12,911 bottles of Levothroid (levothyroxine sodium tablets, USP), 137 mcg, NDC 0456-1331-01. The product was manufactured by Lloyd Pharmaceutical in Shenandoah, IA, for Forest Pharmaceuticals, Inc. in St. Louis, MO.
The recall was initiated due to Current Good Manufacturing Practice (cGMP) deviations. Following a quality review of stability failures in previous lots, the firm determined there is insufficient data to confirm that other lots are not affected.
The bulk product was distributed to Forest Laboratories, Inc., which repackaged it into 100-tablet bottles. Distribution was made to 75 customers nationwide and in Puerto Rico. The affected lot number is 1096372, with an expiration date of May-13. Consumers should contact their healthcare provider or pharmacist for guidance on this prescription medication.
The recalled product
- Product
- Levothroid (levothyroxine sodium tablets, USP), 137 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1331-01.
- Manufacturer
- Lloyd Inc. of Iowa
- Category
- Drug — Thyroid Hormone
- Affected units
- 12,911
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 1096372
- Exp May-13.
Distribution
Part of a larger recall action
This product is one of 20 recalled by Lloyd Inc. of Iowa under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 20 products in this recall →Related recalls
Same manufacturer · Lloyd Inc. of Iowa
See all →- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to cGMP Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Control Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Stability Failures
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14